U.S. Beverage Stock News

NYSE:ASAN
NYSE:ASANSoftware

Assessing Asana (ASAN) Valuation As Recent Returns Contrast With Long-Term Momentum

Setting the scene for Asana stock Asana (ASAN) has been on investors’ radar after recent trading, with the stock closing at $7.05. With mixed short and longer term returns, many are reassessing how its work management platform fits their portfolio. See our latest analysis for Asana. Recent trading has pushed Asana’s 7 day share price return to 11.55% and 30 day return to 13.71%. However, the year to date share price return of 45.60% and 1 year total shareholder return of 59.13% indicate that...
NasdaqCM:CPRX
NasdaqCM:CPRXBiotechs

A Look At Catalyst Pharmaceuticals (CPRX) Valuation After Recent Share Price Momentum

Why Catalyst Pharmaceuticals Stock Is On Investors’ Radar Catalyst Pharmaceuticals (CPRX) has drawn attention after a period of strong share-price moves, with returns over the past month, past 3 months and year all in positive territory according to recent performance data. For investors tracking US biopharmaceutical stocks focused on rare diseases, this kind of sustained positive return profile can prompt a closer look at how the current share price relates to earnings, profitability and...
NasdaqGS:SOFI
NasdaqGS:SOFIConsumer Finance

A Look At SoFi Technologies (SOFI) Valuation After Strong Q1 2026 Earnings And Membership Growth

SoFi Technologies (SOFI) has drawn fresh attention after reporting Q1 2026 earnings that included US$1.1b in net revenue, net income of US$166.7 million, and record loan and deposit balances. See our latest analysis for SoFi Technologies. Despite strong Q1 results, SoFi’s recent 1-day and 90-day share price returns of 1.84% and 23.3% declines contrast with a 1-year total shareholder return of 20.66% and a 3-year total shareholder return above 3x. This points to fading near term momentum but...
NYSE:DHR
NYSE:DHRLife Sciences

Assessing Danaher (DHR) Valuation As Shares Weaken And Undervaluation Debate Grows

Why Danaher Stock Is On Investors’ Radar Now Danaher (DHR) has drawn fresh attention after recent share price moves, with the stock showing a return of about 0.4% over the past day but weaker performance across the month and past 3 months. See our latest analysis for Danaher. At a share price of $175.66, Danaher's recent 30 day share price return of an 8.0% decline and year to date share price return of a 23.8% decline suggest momentum has been fading, despite a smaller 9.2% decline in the 1...
NasdaqGS:HWKN
NasdaqGS:HWKNChemicals

Evaluating Hawkins (HWKN) Valuation After Strong Recent Share Price Momentum

Why Hawkins (HWKN) Is On Investors’ Radar Recent trading in Hawkins (HWKN) has drawn attention after the stock’s recent month and past 3 months performance, prompting investors to reassess what the current price of $167.01 implies. With returns of 13.88% over the past month and 24.28% in the past 3 months, Hawkins’ recent move sits against a backdrop of longer term total returns and a business spanning water treatment, industrial chemicals, and health and nutrition ingredients. See our latest...
NasdaqGM:AUPH
NasdaqGM:AUPHBiotechs

A Look At Aurinia Pharmaceuticals (AUPH) Valuation After Strong Q1 2026 Earnings Beat

Aurinia Pharmaceuticals (AUPH) has drawn fresh attention after reporting first quarter 2026 results. Revenue was US$77.71 million and net income was US$34.36 million, both higher than the prior year period. See our latest analysis for Aurinia Pharmaceuticals. The earnings beat and reiterated 2026 guidance arrived alongside a 4.9% 90 day share price return and an 86.7% 1 year total shareholder return, suggesting strong recent momentum despite short term share price weakness. If Aurinia’s...
NYSE:CCK
NYSE:CCKPackaging

A Look At Crown Holdings (CCK) Valuation After Q1 Earnings And Dividend Confirmation

Earnings and dividend announcement set the tone for Crown Holdings stock Crown Holdings (CCK) recently reported first quarter 2026 results alongside an affirmation of its regular quarterly dividend, giving investors fresh information on both the company’s operating performance and its ongoing cash return policy. See our latest analysis for Crown Holdings. The recent earnings release, which showed quarterly sales of US$3,259 million and net income of US$175 million, together with the affirmed...
NYSE:BUR
NYSE:BURDiversified Financial

How Burford’s US$1.72 Billion YPF Charge and New Leaders Will Impact Burford Capital (BUR) Investors

In May 2026, Burford Capital reported a very large non-cash revenue loss of US$1.72 billion and a net loss of US$1.63 billion for the first quarter, primarily linked to a capital provision tied to the reversal of its YPF judgment, while also strengthening liquidity through new long-dated debt. At the same time, Burford reshaped its leadership bench by appointing Travis Lenkner as Chief Operating Officer and promoting Carrie Tendler to lead Asset Recovery, signaling a focus on execution,...
NasdaqGS:CMPR
NasdaqGS:CMPRCommercial Services

How Cimpress’ Swing to Q3 Profit and Stronger Margins At Cimpress (CMPR) Has Changed Its Investment Story

Cimpress plc has reported past third-quarter 2026 results showing sales of US$886.21 million versus US$789.47 million a year earlier, with net income of US$13.84 million compared with a net loss of US$8.24 million and basic earnings per share from continuing operations improving from US$0.33 loss to US$0.57. Over the first nine months to March 31, 2026, Cimpress lifted sales to US$2.79 billion and more than doubled net income to US$70.82 million, highlighting materially stronger...
NYSE:WD
NYSE:WDDiversified Financial

Why Walker & Dunlop (WD) Is Up 8.9% After Strong Q1 2026 Results And Dividend Affirmation

Walker & Dunlop, Inc. has reported past first-quarter 2026 results, with revenue rising to US$301.33 million and net income to US$15.87 million, alongside affirming a quarterly dividend of US$0.68 per share payable on June 4, 2026. Beneath these headline figures, the company highlighted very large growth in transaction volumes and agency lending, supported by complex refinancing deals and higher productivity per banker that helped increase its share of the GSE lending market. We’ll now...
NasdaqGS:MMYT
NasdaqGS:MMYTHospitality

Assessing MakeMyTrip (NasdaqGS:MMYT) Valuation After Recent Share Price Momentum

What recent returns say about MakeMyTrip stock MakeMyTrip (MMYT) has moved sharply in recent months, with a 2.1% gain over the past day, about 7% over the past week, and roughly 32% over the past month. See our latest analysis for MakeMyTrip. While the recent 32% 1 month share price return points to strong short term momentum, this comes after a 38.3% year to date share price decline and a 48% 1 year total shareholder return loss, set against much stronger 3 and 5 year total shareholder...
NYSE:AWI
NYSE:AWIBuilding

A Look At Armstrong World Industries (AWI) Valuation After Its First Quarter 2026 Earnings Update

Armstrong World Industries (AWI) has put investors on alert after its first quarter 2026 update, combining higher year-on-year sales, slightly lower net income and a reaffirmed full year net sales outlook. See our latest analysis for Armstrong World Industries. The reaffirmed 2026 net sales outlook and management's focus on M&A have come after a 16.7% decline in the 90 day share price return, even as the 3 year total shareholder return sits at 157.8%. This suggests long term momentum has been...
NYSE:J
NYSE:JProfessional Services

Jacobs Sydney Metro Win Highlights Undervalued Infrastructure Growth Story

Jacobs Solutions (NYSE:J) has been selected as part of a joint venture to design five new underground stations for Sydney Metro West. The contract covers integrated engineering design services for Australia’s largest transportation project. The win expands Jacobs Solutions’ global transportation infrastructure footprint, with a focus on high-performance, sustainable mass transit. For investors watching the infrastructure and engineering space, this new Sydney Metro West mandate puts Jacobs...
NYSE:PEB
NYSE:PEBHotel and Resort REITs

A Look At Pebblebrook Hotel Trust (PEB) Valuation After Recent Share Price Strength

Pebblebrook Hotel Trust stock moves draw investor focus Pebblebrook Hotel Trust (PEB) is back on many investors’ radars after a recent stretch of positive share price performance, with the stock up over the past month and past 3 months. See our latest analysis for Pebblebrook Hotel Trust. That recent upswing fits into a broader recovery story, with a 30 day share price return of 13.88% and a 1 year total shareholder return of 53.71% pointing to improving momentum despite a weak 5 year total...
NYSE:CC
NYSE:CCChemicals

Assessing Chemours (CC) Valuation After Q1 Earnings Beat And Reaffirmed Guidance

Why Chemours stock is on investors’ radar Chemours (CC) has drawn fresh attention after its first quarter 2026 earnings, where several business segments outperformed expectations, and management highlighted debt reduction, refinancing activity, and reaffirmed full year sales and EBITDA guidance. See our latest analysis for Chemours. That interest has come against a sharp pullback in recent days, with a 1 day share price return of 5.32% decline and a 7 day share price return of 16.85% decline,...
NYSE:SCL
NYSE:SCLChemicals

How Stepan’s Swing to Q1 Loss With Steady Dividend At Stepan (SCL) Has Changed Its Investment Story

Stepan Company reported past first-quarter 2026 results showing sales of US$604.51 million versus US$593.26 million a year earlier, but it swung from net income of US$19.71 million to a net loss of US$41.41 million, with basic and diluted loss per share from continuing operations of US$1.81 compared with earnings of US$0.86. Despite the move into loss-making territory, Stepan maintained its shareholder payout by affirming a quarterly dividend of US$0.395 per share, payable on June 15, 2026,...
NasdaqGS:KHC
NasdaqGS:KHCFood

Kraft Heinz (KHC) Is Up 6.5% After Q1 Beat, Buybacks And Debt Tender - What's Changed

The Kraft Heinz Company recently reported first-quarter 2026 results, with sales of US$6,047 million, net income of US$798 million, basic EPS of US$0.67, a US$13 million goodwill and intangible impairment, and affirmed a quarterly dividend of US$0.40 per share payable on June 26, 2026. Alongside early progress in its turnaround under new CEO Steve Cahillane, the company has completed a US$1.51 billion share repurchase program and launched a US$1.10 billion tender offer to reshape its...
NYSE:DOCS
NYSE:DOCSHealthcare Services

Assessing Doximity (DOCS) Valuation As Analyst Forecasts Shift Before Key Earnings Release

Doximity (DOCS) is back in focus after its share price reacted to shifting analyst forecasts ahead of the upcoming earnings release, with investors weighing expectations for lower EPS against modest revenue growth. See our latest analysis for Doximity. The stock has staged a short term rebound, with a 7 day share price return of 6.51% and a 30 day share price return of 15.69%. However, this sits against a year to date share price return decline of 39.87% and a 1 year total shareholder return...
NasdaqGS:SBCF
NasdaqGS:SBCFBanks

Will Rising Net Interest Income And Share Buybacks Change Seacoast Banking Corporation of Florida's (SBCF) Narrative

In April 2026, Seacoast Banking Corporation of Florida reported first-quarter 2026 results, with net interest income rising to US$176.47 million from US$118.52 million a year earlier, while net income was broadly flat at US$31.9 million and diluted EPS from continuing operations eased to US$0.29 from US$0.37. Over the same quarter, Seacoast also completed a buyback of 317,628 shares for US$10.23 million, a small but clear signal of ongoing capital return alongside its mixed earnings...
NasdaqGS:DUOL
NasdaqGS:DUOLConsumer Services

The Bull Case For Duolingo (DUOL) Could Change Following Sharper Q1 Profitability And Raised EBITDA Guidance

In early May 2026, Duolingo, Inc. reported first-quarter 2026 results showing sales of US$291.97 million and net income of US$43.46 million, with both basic and diluted earnings per share from continuing operations increasing compared with the prior year. Beyond the headline growth, Duolingo’s results highlighted stronger profitability, continued expansion into new subjects like Chess and Math, and a user-engagement focus that aims to balance monetization with long-term platform health. With...
NYSE:IHS
NYSE:IHSTelecom

IHS Holding Sells I‑Systems Stake And Refocuses On Core Tower Assets

IHS Holding (NYSE:IHS) has completed the divestment of its 51% stake in Brazilian fiber infrastructure venture I-Systems. The stake has been sold to TIM S.A., marking IHS Holding's exit from this Brazilian optical fiber joint venture. IHS Holding, trading at $8.23, has seen its stock return 12.0% year to date and 44.1% over the past year, while its 3 year return stands at 9.2%. This completed I-Systems divestment gives investors a fresh development to consider alongside those share price...
NasdaqGS:MMSI
NasdaqGS:MMSIMedical Equipment

Is Merit Medical Systems (MMSI) Pricing Look Attractive After Steep One Year Share Price Slide

If you are wondering whether Merit Medical Systems is starting to look interesting at its current share price, this article focuses squarely on what that price might imply about value. The stock last closed at US$62.33, with recent returns of an 8.6% decline over 7 days, a 7.5% decline over 30 days, a 27.9% decline year to date, and a 35.1% decline over the past year. These moves have put the stock back on many watchlists, as investors reassess what they are willing to pay for medical...
NasdaqGS:NCNO
NasdaqGS:NCNOSoftware

The Bull Case For nCino (NCNO) Could Change Following Major European Lending Platform Win

nCino recently won significant banking clients, including being selected by Raiffeisenbankengruppe Oesterreich as its unified corporate lending platform and by Vision Credit Union to modernize agricultural and commercial lending with AI-enabled tools. These client wins, alongside new leadership appointments such as a Chief Revenue Officer and Asia-Pacific Managing Director, highlight nCino’s push to deepen international reach and scale its AI-focused banking platform. We’ll now look at how...
NasdaqGS:CLOV
NasdaqGS:CLOVHealthcare

Evaluating Clover Health Investments (CLOV) Valuation After A Sharp Short‑Term Share Price Rebound

What recent performance says about Clover Health Investments (CLOV) Clover Health Investments (CLOV) has attracted fresh attention after a sharp share price move, with the stock showing a 5.2% gain over the past day and a 48.4% gain over the past month. See our latest analysis for Clover Health Investments. The recent 48.4% 1-month share price return sits against a 17.0% share price return year to date and a 24.8% decline in the 1-year total shareholder return. This points to momentum...